In reviewing the literature, we found that the CD8/Foxp3 ratio had a positive effect on prognosis in a number of tumours, including osteosarcoma, colorectal cancer and breast cancer [21, 33, 37–39]. The gene discussed is CD8A; the disease is neoplasm.